Deutsche Bank’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $235K | Sell |
14,678
-3,333
| -19% | -$53.3K | ﹤0.01% | 2860 |
|
|
2025
Q1 | $274K | Sell |
18,011
-1,997
| -10% | -$30.4K | ﹤0.01% | 2773 |
|
|
2024
Q4 | $406K | Buy |
20,008
+7,025
| +54% | +$142K | ﹤0.01% | 2689 |
|
|
2024
Q3 | $334K | Buy |
12,983
+3,680
| +40% | +$94.6K | ﹤0.01% | 2628 |
|
|
2024
Q2 | $120K | Buy |
+9,303
| New | +$120K | ﹤0.01% | 3018 |
|
|
2023
Q2 | – | Sell |
-1,415
| Closed | -$26.6K | – | 3846 |
|
|
2023
Q1 | $26.6K | Buy |
1,415
+538
| +61% | +$10.1K | ﹤0.01% | 3649 |
|
|
2022
Q4 | $8.94K | Buy |
877
+16
| +2% | +$163 | ﹤0.01% | 3798 |
|
|
2022
Q3 | $23K | Sell |
861
-150
| -15% | -$4.01K | ﹤0.01% | 3696 |
|
|
2022
Q2 | $46K | Sell |
1,011
-146
| -13% | -$6.64K | ﹤0.01% | 3740 |
|
|
2022
Q1 | $114K | Sell |
1,157
-138
| -11% | -$13.6K | ﹤0.01% | 3504 |
|
|
2021
Q4 | $198K | Buy |
1,295
+767
| +145% | +$117K | ﹤0.01% | 3357 |
|
|
2021
Q3 | $72K | Sell |
528
-1
| -0.2% | -$136 | ﹤0.01% | 3917 |
|
|
2021
Q2 | $78K | Buy |
+529
| New | +$78K | ﹤0.01% | 4101 |
|